After the completion and refinement of the human genome, the characterization of individual gene products in respect of their functions, their modifications, their cellular localization and regulation in both space and time has generated an increased demand for antibodies for their analysis. Taking into account that the human genome contains not, vert, similar25,000 genes, and that their products are found in different splice variants and produce proteins with post-translational modifications, it can be estimated that at least 100,000 different protein products have to be investigated to gain a complete picture of what's going on in the proteome of a cell. Antibodies are preferred tools helping with the characterization and detection of pro...
We developed and optimized a high-throughput project workflow to generate renewable recombinant anti...
Recombinant human antibody technology has been the cornerstone of the uprising of biologics in the p...
During the last 15 years in vitro technologies opened powerful routes to combine the generation of l...
After the completion and refinement of the human genome, the characterization of individual gene pro...
Despite the wealth of commercially available antibodies to human proteins, research is often hindere...
In vitro display technologies, best exemplified by phage and yeast display, were first described for...
Antibodies leverage on their unique architecture to bind with an array of antigens. The strength of ...
As many genome sequencing efforts today are completed, we are now provided with the genetic maps for...
The immune system is an important part of the physiology of higher organisms. In the immune system a...
The number of therapeutic antibodies in preclinical, clinical, or approved phases has been increasin...
<div><p>We developed and optimized a high-throughput project workflow to generate renewable recombin...
After several decades of optimization, phage display technology enables the routine isolation and pr...
We have created a high quality phage display library containing over 1010 human antibodies and descr...
During the last 15 years in vitro technologies opened powerful routes to combine the generation of l...
Phage display technology has emerged as the dominant approach in antibody engineering. Here I descri...
We developed and optimized a high-throughput project workflow to generate renewable recombinant anti...
Recombinant human antibody technology has been the cornerstone of the uprising of biologics in the p...
During the last 15 years in vitro technologies opened powerful routes to combine the generation of l...
After the completion and refinement of the human genome, the characterization of individual gene pro...
Despite the wealth of commercially available antibodies to human proteins, research is often hindere...
In vitro display technologies, best exemplified by phage and yeast display, were first described for...
Antibodies leverage on their unique architecture to bind with an array of antigens. The strength of ...
As many genome sequencing efforts today are completed, we are now provided with the genetic maps for...
The immune system is an important part of the physiology of higher organisms. In the immune system a...
The number of therapeutic antibodies in preclinical, clinical, or approved phases has been increasin...
<div><p>We developed and optimized a high-throughput project workflow to generate renewable recombin...
After several decades of optimization, phage display technology enables the routine isolation and pr...
We have created a high quality phage display library containing over 1010 human antibodies and descr...
During the last 15 years in vitro technologies opened powerful routes to combine the generation of l...
Phage display technology has emerged as the dominant approach in antibody engineering. Here I descri...
We developed and optimized a high-throughput project workflow to generate renewable recombinant anti...
Recombinant human antibody technology has been the cornerstone of the uprising of biologics in the p...
During the last 15 years in vitro technologies opened powerful routes to combine the generation of l...